X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet   (REDY)

Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 1,931.9
Mkt Cap Rs m 320,127
Vol '000 11.4
P/E X 31.9
P/CF X 14.0
EPS (TTM) Rs 60.6
% ch % -2.3
No. of shares m 165.71
% ch week % -3.0
% ch 1-mth % -7.9
% ch 12-mth % -27.9
52 week H/L Rs 2,788.0/1,901.7
(As on May 21, 2018 12:19:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs1,9692,9403,6624,3833,397 
Low Rs1,5281,7662,2502,7502,560 
Sales per share (Unadj.) Rs700.4788.6881.8912.5856.5 
Earnings per share (Unadj.) Rs89.9115.4137.1124.978.0 
Diluted earnings per shareRs92.1118.5141.0128.678.0 
Cash flow per share (Unadj.) Rs122.3153.5181.7179.9139.9 
Dividends per share (Unadj.) Rs15.0018.0020.0020.0020.00 
Adj. dividends per shareRs15.3718.4820.5620.5920.00 
Dividend yield (eoy) %0.90.80.70.60.7 
Book value per share (Unadj.) Rs375.0462.4635.8736.8739.8 
Adj. book value per shareRs384.4474.6653.8758.5740.0 
Shares outstanding (eoy) m169.84170.11170.38170.61165.74 
Bonus/Rights/Conversions  ESOPESOPESOPESOPBB 
Price / Sales ratio x2.53.03.43.93.5 
Avg P/E ratio x19.520.421.628.638.2 
P/CF ratio (eoy) x14.315.316.319.821.3 
Price / Book Value ratio x4.75.14.64.84.0 
Dividend payout %16.715.614.616.025.7 
Avg Mkt Cap Rs m296,965400,277503,643608,481493,632 
No. of employees `00016.519.019.921.722.7 
Total wages/salary Rs m19,28724,75429,44631,17431,068 
Avg. sales/employee Rs Th7,209.57,060.77,565.77,184.66,259.0 
Avg. wages/employee Rs Th1,168.91,302.81,482.91,438.61,369.8 
Avg. net profit/employee Rs Th925.31,033.31,176.6983.2569.7 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m118,956134,153150,233155,683141,961 
Other income Rs m1,4991,6972,7412,9501,715 
Total revenues Rs m120,455135,850152,974158,633143,676 
Gross profit Rs m27,19532,50834,93635,85324,722 
Depreciation Rs m5,5026,4757,5999,38910,266 
Interest Rs m1,0031,2671,082826634 
Profit before tax Rs m22,18926,46328,99628,58815,537 
Minority Interest Rs m00000 
Prior Period Items Rs m000229349 
Extraordinary Inc (Exp) Rs m-5420000 
Tax Rs m6,3796,8315,6327,5112,965 
Profit after tax Rs m15,26819,63223,36421,30612,921 
Gross profit margin %22.924.223.323.017.4 
Effective tax rate %28.725.819.426.319.1 
Net profit margin %12.814.615.613.79.1 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m85,267103,257118,096117,94096,837 
Current liabilities Rs m56,58857,90463,73463,47184,199 
Net working cap to sales %24.133.836.235.08.9 
Current ratio x1.51.81.91.91.2 
Inventory Days Days6766626073 
Debtors Days Days9890999798 
Net fixed assets Rs m46,15952,79659,06573,352102,552 
Share capital Rs m849851852853829 
"Free" reserves Rs m56,36472,946107,482124,845121,792 
Net worth Rs m63,69178,652108,334125,698122,621 
Long term debt Rs m12,65920,75514,30710,6855,449 
Total assets Rs m134,872160,296190,650203,841218,165 
Interest coverage x23.121.927.835.625.5 
Debt to equity ratio x0.20.30.10.10 
Sales to assets ratio x0.90.80.80.80.7 
Return on assets %12.113.012.810.96.2 
Return on equity %24.025.021.617.010.5 
Return on capital %29.727.924.521.712.9 
Exports to sales %51.355.249.446.654.6 
Imports to sales %9.78.99.09.09.4 
Exports (fob) Rs m61,00474,05974,14672,61877,520 
Imports (cif) Rs m11,48711,95913,48514,05013,274 
Fx inflow Rs m64,29076,00774,87075,40581,670 
Fx outflow Rs m20,12524,60726,00827,11526,355 
Net fx Rs m44,16551,40048,86248,29055,315 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 13,779 19,697 25,235 32,626 21,444 
From Investments Rs m -14,463 -16,941 -22,647 -20,394 -18,404 
From Financial Activity Rs m -1,568 -242 -4,332 -17,001 -3,692 
Net Cashflow Rs m -2,252 2,514 -1,744 -474 -1,144 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare DR. REDDYS LAB With:   NATCO PHARMA  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Ultratech Cement Gains 3.6%(09:30 am)

Asian shares are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.5% while the Hang Seng is up 1.2%.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - CADILA HEALTHCARE COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS